PENNSAID^®

Topical NSAID – Combines 2% diclofenac sodium with the transdermal drug carrier dimethyl sulfoxide (DMSO).

• Indication: Treating the pain of osteoarthritis of the knee.
• Formulation:
  • Low systemic exposure to minimize side effects.
  • Metered dose dispenser.
• Intellectual Property
  • Patents issued in nineteen countries (ex-U.S.) and pending in five countries with the latest expiring 2027.

  Awaiting DCGI approval

For more information on PENNSAID^®
Please refer https://www.pennsaid.com/ or​

For any medical enquiry

Contact us at: +91 9591736262 or
Email us at info@sayretherapeutics.com